132 related articles for article (PubMed ID: 32652067)
1. Predictive Factors for Lymph Node Metastasis in Clinical Stage I Part-Solid Lung Adenocarcinoma.
Lee SY; Jeon JH; Jung W; Chae M; Hwang WJ; Hwang Y; Cho S; Chung JH; Kim K; Jheon S
Ann Thorac Surg; 2021 Feb; 111(2):456-462. PubMed ID: 32652067
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
5. A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non-Small-Cell Lung Cancer.
Mattes MD; Weber WA; Foster A; Moshchinsky AB; Ahsanuddin S; Zhang Z; Shi W; Rizk NP; Wu AJ; Ashamalla H; Rimner A
J Thorac Oncol; 2015 Aug; 10(8):1207-12. PubMed ID: 26200276
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
[TBL] [Abstract][Full Text] [Related]
7. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
[TBL] [Abstract][Full Text] [Related]
8. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
9. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H; Goo JM; Suh YJ; Park CM; Kim YT
Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
[TBL] [Abstract][Full Text] [Related]
10. Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Cho JY; Leem CS; Kim Y; Kim ES; Lee SH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
BMC Pulm Med; 2018 Sep; 18(1):151. PubMed ID: 30200917
[TBL] [Abstract][Full Text] [Related]
11. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
13. Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2018 Oct; 106(4):989-997. PubMed ID: 29852148
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
[TBL] [Abstract][Full Text] [Related]
15. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
[TBL] [Abstract][Full Text] [Related]
17. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.
Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J
Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295
[TBL] [Abstract][Full Text] [Related]
18. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
19. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
[TBL] [Abstract][Full Text] [Related]
20. Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.
Fukui T; Kato K; Okasaka T; Kawaguchi K; Fukumoto K; Nakamura S; Hakiri S; Ozeki N; Yokoi K
Gen Thorac Cardiovasc Surg; 2017 Nov; 65(11):640-645. PubMed ID: 28866794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
